Showing results (171-180 of 233) with videos related to
Sort By:
Pageof 24
Bulletin Du Cancer|November 20, 2001
[Standards, options and recommendations: nutritional support in palliative or terminal care of adult patients with progressive cancer]P Bachmann, C Marti-Massoud, M P Blanc-Vincent, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distributionD Elias, M Bonnay, J M Puizillou, et al.Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumorsT Walter, D Planchard, K Bouledrak, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II studyP Schöffski, B Besse, T Gauler, et al.Cancer Treatment Reviews|November 19, 2025
Angiogenesis and thymic epithelial tumors: from preclinical insights to different therapeutic lines and combination strategiesD Miliziano, C Sciortino, S Manglaviti, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced diseaseB Besse, A Adjei, P Baas, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 26, 2013
Phase II study of everolimus-erlotinib in previously treated patients with advanced non-small-cell lung cancerB Besse, N Leighl, J Bennouna, et al.ESMO Open|September 20, 2021
Osimertinib plus platinum-pemetrexed in newly diagnosed epidermal growth factor receptor mutation-positive advanced/metastatic non-small-cell lung cancer: safety run-in results from the FLAURA2 studyD Planchard, P-H Feng, N Karaseva, et al.Heart Rhythm|November 17, 2009
Mechanisms of sinoatrial node dysfunction in a canine model of pacing-induced atrial fibrillationBoyoung Joung, Shien-Fong Lin, Zhenhui Chen, et al.British Journal of Cancer|August 11, 2011
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomasF Farace, C Massard, N Vimond, et al.Pageof 24